Goldfine, Allison B.
Brigham and Women’s Hospital,
United States
2025 Rank: 66904
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Endocrinology & Metabolism
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 958 out of 96207 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 66904 | 69991 |
| Total Cites | 1311 | 1381 |
| H-index | 14 | 15 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 50 | 50 |
| Total Cites to Single+First Authored Papers | 90 | 94 |
| Number of Single+First+Last Authored Papers | 104 | 104 |
| Total Cites to Single+First+Last Authored Papers | 543 | 564 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1205 | 1254 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.10 |
| Self-Citation Percentage |
5.07%
|
|
Goldfine, Allison B.
Biomedical Research at Novartis,
United States
2024 Rank: 48537
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Endocrinology & Metabolism
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 752 out of 92197 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 48537 | 53579 |
| Total Cites | 1368 | 1419 |
| H-index | 15 | 16 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 4 | 4 |
| Number of Single+First Authored Papers | 50 | 50 |
| Total Cites to Single+First Authored Papers | 110 | 112 |
| Number of Single+First+Last Authored Papers | 105 | 105 |
| Total Cites to Single+First+Last Authored Papers | 581 | 588 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1273 | 1311 |
| Ratio of Total Citations to Distinct Citing Papers | 1.07 | 1.08 |
| Self-Citation Percentage |
3.59%
|
|
Goldfine, Allison B.
Harvard Medical School,
United States
2021 Rank: 28190
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Endocrinology & Metabolism
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 524 out of 81805 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 28190 | 29587 |
| Total Cites | 2609 | 2723 |
| H-index | 22 | 23 |
| Hm-index | 7 | 8 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 9 | 9 |
| Number of Single+First Authored Papers | 50 | 50 |
| Total Cites to Single+First Authored Papers | 203 | 212 |
| Number of Single+First+Last Authored Papers | 104 | 104 |
| Total Cites to Single+First+Last Authored Papers | 1042 | 1064 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2423 | 2499 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.09 |
| Self-Citation Percentage |
4.19%
|
|
Goldfine, Allison B.
Harvard Medical School,
United States
2020 Rank: 22020
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Endocrinology & Metabolism
SubField 2:
Cardiovascular System & Hematology
Rank in SubField 1: 429 out of 69094 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 22020 | 24122 |
| Total Cites | 1988 | 2086 |
| H-index | 19 | 20 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 12 | 12 |
| Number of Single+First Authored Papers | 50 | 50 |
| Total Cites to Single+First Authored Papers | 158 | 165 |
| Number of Single+First+Last Authored Papers | 104 | 104 |
| Total Cites to Single+First+Last Authored Papers | 811 | 833 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1805 | 1879 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.11 |
| Self-Citation Percentage |
4.70%
|
|